Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 26, 2024
Univo IRB announced the launch of its Canadian research ethics board (REB) review services. This new offering is designed to support clinical trials conducted across North America, ensuring that reviews exceed the industry’s highest standards of ...
read more
Thursday, September 26, 2024
Phesi has launched a self-service Investigator Site Profile solution designed to eliminate the non-active and non-enrolling investigator sites that development programs are typically burdened with. Investigator Site Profile leverages data from Phesi’...
read more
Tuesday, September 24, 2024
Lonza announced the signature of a long-term commercial supply agreement for CASGEVY® (exagamglogene autotemcel).
read more
Tuesday, September 24, 2024
Univo IRB announced the launch of its Canadian research ethics board (REB) review services. This new offering is designed to support clinical trials conducted across North America, ensuring that reviews exceed the industry’s highest standards of ...
read more
Tuesday, September 24, 2024
Ascend Advanced Therapies (Ascend), a gene to GMP development partner, has confirmed multi-million-dollar investments supporting global infrastructure of the company. Expanded GMP suite capacity up to 500L scales and the addition of fill finish ...
read more
Thursday, September 19, 2024
Piramal Pharma Limited embarked on its sustainability journey as the Science Based Targets initiative (SBTi) officially validated the company’s near-term greenhouse gas (GHG) emission reduction targets.
read more
Thursday, September 19, 2024
Leading global contract development and manufacturing organization (CDMO), PCI Pharma Services (PCI), has successfully completed the International Coalition of Medicines Regulatory Authorities (ICMRA) inspection of its Bedford, New Hampshire campus.
read more
Tuesday, September 17, 2024
Serán Bioscience announced a strategic growth transaction of more than $200 million. Bain Capital Life Sciences led the transaction, while existing investor Vivo Capital remains a key shareholder in the company.
read more
Tuesday, September 17, 2024
Eurofins Scientific announced the closing of its acquisition of Infinity Laboratories, Inc. Founded in 1991, Infinity operates eight state-of-the-art laboratories across the United States and employs approximately 100 staff.
read more
Tuesday, September 17, 2024
Recipharm announced a significant investment in its Oral Solid Development and Pilot Scale Centre in Zwickau, Germany. The investment includes three new GMP Pilot Scale suites for blending, tableting and hard capsule filling, which will complement ...
read more
Tuesday, September 17, 2024
PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has acquired BTS Research, a San Diego-based preclinical contract research organization (CRO).
read more
Tuesday, September 17, 2024
Advanco has launched a strategic partnership with Arvato Systems which will offer pharmaceutical clients some of the most powerful serialization solutions available on the market today.
read more
Thursday, September 12, 2024
Temperature-controlled container specialists Tower Cold Chain and CRYOPDP have partnered to enhance their product offerings to the pharmaceutical supply chain. The collaboration aims to provide an expanded range of solutions, specifically for ...
read more
Thursday, September 12, 2024
PharmaForceIQ (PFIQ), the leading end to end Omnichannel Solution for Pharmaceutical Marketing, Medical and Clinical teams today announced a significant investment by Eir Partners (Eir) to accelerate adoption of the company’s unique technology ...
read more
Wednesday, September 11, 2024
VS-041, a novel and potentially life-saving treatment for heart failure, developed by Vasa Therapeutics, a San Diego-based biotechnology company, has reached a major clinical milestone with the first human subjects dosed at Quotient Sciences’ ...
read more